Anti-Diversion & Local Manufacturing
Part of: OWN · Chemistry & Materials · Bio, Agro & Food
For Governments
You want to stop commodity diversion — and build local manufacturing that supplies your own health system.
Audits show 25% of donor commodities are stolen or diverted. You lose ARVs, malaria nets, and diagnostics to black markets. You need blockchain visibility and local production. We give you the anti-diversion toolkit — then you run the audits.
✅ You track every pill from port to patient — in real time.
✅ You stop theft — and recover diverted commodities.
✅ Your local manufacturers supply donor-funded programs, reducing import dependence.
-
What's holding you back: the diversion economy
Stolen donor commodities are sold in open markets — sometimes across borders. You lose millions of dollars of life-saving medicines. And when audits happen, you are blamed for lack of visibility.
You've seen this:
“We found ARVs being sold in a market — they had 'Not For Sale' labels.”
“The audit said 25% of commodities were diverted — but no one could tell us where or when.”
“We want to track everything, but the systems are too expensive.”
We give you affordable, government-owned tracking. Blockchain and GS1 barcoding that you control — not a foreign contractor.
Your Plan — 3 steps you take with our tools
1. Map your supply chain risks
We give you a risk assessment tool. You identify which commodities are most diverted, which warehouses have no inventory control, and which transport routes are insecure.
2. Deploy blockchain tracking
You decide: full blockchain for high-value items (ARVs, diagnostics) or simpler barcoding for others. We provide the software and hardware — you host the data on your servers.
3. Train your auditors and transition
We train your supply chain staff to run the system and interpret alerts. After 12–18 months, you manage all monitoring. You also get a local manufacturing roadmap to produce essential commodities.
For Donors
You want proof that the commodities you fund reach patients — not a lost 25% you find out about only when the audit lands.
It's not a trust issue — it's a visibility gap you're currently paying to not have.
You fund ARVs, malaria nets, and diagnostics, and right now you have no real-time way to know they reached the patients they were meant for. Diversion is typically discovered retrospectively – an audit finds 25% missing, months after the commodities disappeared, by which point recovery is close to impossible and the loss is simply absorbed. That's not a trust problem with your government partner. It's a visibility gap in the system itself, and it's costing you real money every cycle.
Blockchain and GS1 tracking exist to close that gap while there's still time to act – not to explain it after the fact.
-
Your wins with Chemistry & Materials, as a donor:
✅ You get real-time, port-to-patient tracking of the exact commodities you funded – not a retrospective audit finding out where 25% went six months later.
✅ You see diverted commodities recovered, not just documented as a loss – real-time alerts make intervention possible before the trail goes cold.
✅ Your funding supports local manufacturing that reduces the country's import dependence – meaning fewer future shipments exposed to the same diversion risk in the first place.
“Within the first tracking cycle, you see exactly where your funded commodities are, in real time – not a 25% loss you learn about from an audit six months after the fact.”
This is the same principle behind our broader OWN pillar: real-time, blockchain-verified visibility that protects your investment, hosted on infrastructure the government controls – not a system you have to take on faith.
For Partners
You want your tracking technology or manufacturing investment to become the system the government actually keeps running — not a pilot that gets shelved once the grant closes.
It's not a technology risk — it's an ownership and market-continuity risk.
If you're bringing blockchain or tracking technology into this program, the real risk isn't whether it works – it's whether the government adopts it as the system they keep, the same adoption risk that affects any donor-funded platform. If you're a local manufacturing partner, the risk looks different: is there a sustained, funded market for what you produce, or is this a one-off contract with no guarantee of future demand?
We design for both risks directly – government ownership from day one for the technology, and a manufacturing roadmap tied to ongoing donor-funded programs for the production side.
-
Your wins with Chemistry & Materials, as a partner:
✅ Your tracking technology is deployed with government-hosted servers and audit logs as the default from day one – not negotiated at handover, avoiding the adoption risk that shelves good pilots.
✅ If you're a manufacturing partner, your production is built into a roadmap explicitly designed to supply ongoing donor-funded programs – a sustained market signal, not a one-off contract.
✅ You train government auditors and supply chain staff as co-operators of the system – not kept as the sole vendor the whole system depends on indefinitely.
“Within 12–18 months, government staff run the tracking and audit system themselves – your technology or manufacturing capacity is proven at scale, not permanently dependent on your continued involvement.”
This runs on the same flexible model as every sector: your technical or industrial contribution is designed to outlast your direct involvement, not depend on it indefinitely.